Rockland Trust Co Stake In Thermo Fisher Scientific INC (TMO) Was Has Boosted

October 6, 2017 - By Dolores Ford

Investors sentiment decreased to 0.91 in 2017 Q2. Its down 0.04, from 0.95 in 2017Q1. It dived, as 43 investors sold TMO shares while 415 reduced holdings. 99 funds opened positions while 316 raised stakes. 323.23 million shares or 1.69% less from 328.77 million shares in 2017Q1 were reported. Point72 Asset LP accumulated 126,605 shares. Regent Management Limited Liability Company stated it has 0.55% in Thermo Fisher Scientific Inc. (NYSE:TMO). Apg Asset Mngmt Nv has invested 0.04% in Thermo Fisher Scientific Inc. (NYSE:TMO). Select Equity Grp LP reported 0% in Thermo Fisher Scientific Inc. (NYSE:TMO). Qci Asset Mngmt Inc New York holds 38 shares. Pathstone Family Office Ltd Limited Liability Company has invested 0.59% in Thermo Fisher Scientific Inc. (NYSE:TMO). Cohen Capital Mngmt Inc holds 79,195 shares. Peloton Wealth Strategists reported 11,937 shares. Meiji Yasuda Life Insur stated it has 23,256 shares or 0.62% of all its holdings. First Long Island Limited Liability Company reported 0.03% stake. Reynders Mcveigh Capital Management Ltd Liability has invested 0.34% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Strs Ohio owns 288,703 shares or 0.22% of their US portfolio. M Kraus & Com accumulated 4.33% or 39,266 shares. Veritas Investment Mgmt (Uk) has 7.34% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). United Svcs Automobile Association has 590,996 shares.

Since May 24, 2017, it had 0 insider purchases, and 3 insider sales for $4.70 million activity. CASPER MARC N had sold 20,000 shares worth $3.46 million on Thursday, June 1. Another trade for 4,688 shares valued at $805,750 was sold by Shine Daniel P.

Rockland Trust Co increased its stake in Thermo Fisher Scientific Inc (TMO) by 98.53% based on its latest 2017Q2 regulatory filing with the SEC. Rockland Trust Co bought 26,682 shares as the company’s stock rose 8.13% with the market. The institutional investor held 53,761 shares of the industrial machinery and components company at the end of 2017Q2, valued at $9.38M, up from 27,079 at the end of the previous reported quarter. Rockland Trust Co who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $76.71 billion market cap company. The stock declined 0.58% or $1.12 reaching $192.31 on the news. About 400,517 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since October 6, 2016 and is uptrending. It has underperformed by 1.13% the S&P500.

More important recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Nasdaq.com which released: “Thermo Fisher Scientific Inc (TMO) Ex-Dividend Date Scheduled for September 14 …” on September 13, 2017, also Forbes.com published article titled: “The One Skill This VP of Finance Looks For Most When Hiring”, Seekingalpha.com published: “Thermo Fisher, Dominant And Growing” on September 21, 2017. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) was released by: Prnewswire.com and their article: “Thermo Fisher Scientific Continues to Expand Plasmid DNA Purification …” with publication date: September 26, 2017.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 17 analysts covering Thermo Fisher Scientific (NYSE:TMO), 16 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Thermo Fisher Scientific had 44 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was upgraded by Cleveland on Thursday, July 20 to “Buy”. The stock has “Buy” rating by Cowen & Co on Friday, September 8. Stifel Nicolaus maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Monday, January 11. Stifel Nicolaus has “Buy” rating and $158 target. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Hold” rating by Jefferies on Friday, April 29. The rating was reinitiated by BTIG Research with “Buy” on Friday, July 22. On Monday, September 25 the stock rating was maintained by Barclays Capital with “Buy”. The stock has “Buy” rating by Mizuho on Tuesday, May 3. The firm has “Hold” rating by Jefferies given on Thursday, March 30. The rating was downgraded by Cleveland on Friday, September 9 to “Neutral”. Mizuho maintained it with “Buy” rating and $160 target in Thursday, July 23 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com